gabapentin and nifedipine

gabapentin has been researched along with nifedipine in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (55.00)29.6817
2010's8 (40.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Bruno-Blanch, L; Gálvez, J; García-Domenech, R1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Alden, KJ; García, J1
Bhargava, VK; Dixit, RK1
Fujita, T; Itoh, Y; Oka, M; Wada, M; Yamamoto, A1
Cosmi, S; Deecher, D; Leventhal, L1
Iwata, S; Koganei, H; Shoji, M1
Behuliak, M; Bencze, M; Kuneš, J; Polgárová, K; Vaněčková, I; Zicha, J1
Ahronowitz, I; Choi, D; Patel, S1
Aleshaki, JS; Gallego, H1

Reviews

1 review(s) available for gabapentin and nifedipine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

19 other study(ies) available for gabapentin and nifedipine

ArticleYear
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship

2003
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Dissociation of charge movement from calcium release and calcium current in skeletal myotubes by gabapentin.
    American journal of physiology. Cell physiology, 2002, Volume: 283, Issue:3

    Topics: Acetates; Amines; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Cyclohexanecarboxylic Acids; Electric Stimulation; Gabapentin; gamma-Aminobutyric Acid; Ion Transport; Membrane Potentials; Mice; Muscle, Skeletal; Nifedipine; Patch-Clamp Techniques; Protein Subunits

2002
Nifedipine potentiates gabapentin antinociception in rats.
    Indian journal of physiology and pharmacology, 2002, Volume: 46, Issue:2

    Topics: Acetates; Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Drug Synergism; Gabapentin; gamma-Aminobutyric Acid; Male; Nifedipine; Pain Measurement; Rats; Rats, Wistar

2002
Gabapentin blocks L-type and P/Q-type Ca2+ channels involved in depolarization-stimulated nitric oxide synthase activity in primary cultures of neurons from mouse cerebral cortex.
    Pharmaceutical research, 2003, Volume: 20, Issue:6

    Topics: Acetates; Amines; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, P-Type; Calcium Channels, Q-Type; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Mice; Molecular Sequence Data; Neurons; Nifedipine; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-Conotoxin GVIA; Potassium Chloride; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2003
Effect of calcium channel modulators on temperature regulation in ovariectomized rats.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:3

    Topics: Amines; Animals; Body Temperature Regulation; Calcium Channel Blockers; Calcium Channels; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Morphine Dependence; Nifedipine; Norethynodrel; Ovariectomy; Rats; Substance Withdrawal Syndrome; Verapamil

2005
Suppression of formalin-induced nociception by cilnidipine, a voltage-dependent calcium channel blocker.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:10

    Topics: Administration, Oral; Amines; Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cyclohexanecarboxylic Acids; Dihydropyridines; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Models, Animal; Nifedipine; omega-Conotoxins; Pain; Rats; Rats, Sprague-Dawley; Spinal Cord

2009
Hemodynamic Response to Gabapentin in Conscious Spontaneously Hypertensive Rats.
    Hypertension (Dallas, Tex. : 1979), 2018, Volume: 72, Issue:3

    Topics: Analgesics; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Consciousness; Gabapentin; Heart Rate; Hypertension; Male; Nifedipine; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Sympathetic Nervous System

2018
Management of refractory pain from hereditary cutaneous leiomyomas with nifedipine and gabapentin.
    Cutis, 2019, Volume: 104, Issue:3

    Topics: Adult; Analgesics; Female; Gabapentin; Humans; Leiomyomatosis; Nifedipine; Pain, Intractable; Skin Neoplasms

2019
Raynaud phenomenon of the nipple successfully treated with nifedipine and gabapentin.
    Cutis, 2020, Volume: 105, Issue:6

    Topics: Adult; Breast Diseases; Breast Feeding; Female; Gabapentin; Humans; Nifedipine; Nipples; Pain; Raynaud Disease; Treatment Outcome

2020